icon-folder.gif   Conference Reports for NATAP  
 
  International Workshop on Antiviral
Drug Resistance
June 3-7 2014, Berlin, Germany
Back grey_arrow_rt.gif
 
 
 
The Prevalence of HCV NS5A, Nucleoside and Protease Inhibitor Resistance Associated Variants and the Effects on Treatment with Ledipasvir/Sofosbuvir RBV in the Phase 3 ION Studies
 
 
  Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-6, 2014
Berlin, Germany
 
Hadas Dvory-Sobol1, Brian Doehle1, Evguenia Svarovskaia1, Joseph F. McCarville1, Phil S. Pang1, Nezam Afdhal2, Kris V. Kowdley3, John McHutchison1, Michael Miller1, and Hongmei Mo1
1Gilead Sciences, Inc., Foster City, CA, USA 2Beth Israel Deaconess Medical Center, Boston, MA, USA
3Digestive Disease Institute, Virginia Mason Medical Center, Seattle, USA

Resist1.gif

Resist2.gif

Resist3.gif

Resist4.gif

Resist5.gif

Resist6.gif

Resist7.gif

Resist8.gif

Resist9.gif

Resist10.gif

Resist11.gif